Policies to address disparities in clinical trials: The EDICT project

Journal of Cancer Education

Volumn 24, Issue SUPPL. 2, 2009, Pages

  Spiker, Cynthia A ^a   Weinberg, Armin D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIALS AS TOPIC; ETHNIC GROUPS; HEALTH POLICY; HEALTHCARE DISPARITIES; HUMANS; MINORITY GROUPS; NEOPLASMS; PATIENT SELECTION; UNITED STATES;

EID: 73649117789     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03182311     Document Type: Review

References (24)

1. Baquet CR, Commiskey P, Mullins CD, Mishra SI. Recruitment and participation in clinical trials: sociodemographic, rural/urban, and health care access predictors. Cancer Detect Prev. 2006; 30:24-33.
2. Corbie-Smith G, Miller WC, Ransohoff, DF. Interpretations of 'appropriate' minority inclusion in clinical research. Am J Med. 2004; 116:249-252 (Pubitemid 38224232)
3. Swanson GM, Bailar JC. Selection and description of cancer clinical trials participants-science or happenstance? Cancer. 2002; 95:950-959.
4. Janson SL, Alioto ME, Boushey HA. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial. Controlled Clinical Trials. 2001;6:S236-S243.
5. Brandon, DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005; 97:951-956.
6. Seto, B. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research. Am J Med Sci. 2001;322:246-250
7. Comis RL, Aldige CR, Stovall EL, Krebs LU, Risher PJ, Taylor HJ. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003:5:830-835.
8. National Cancer Institute. Cancer Clinical Trials: The Basic Workbook. Available from: http://www.cancer.gov/clinicaltrials/resources/basicworkbook. Accessed November 18, 2009.
9. Nguyen TT, Somkin CP, Ma Y. Participation of Asian-American women in cancer chemoprevention research: physician perspectives. Cancer. 2005; 104:3006-3014
10. Killien M, Bigby JA, Champion V, et al. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health. J Womens Health Gend Based Med. 2000; 9:1061-1070
11. Ross S, Grant A, Counsell C, et al. Barriers to participation in randomized controlled trials: a systematic review. J Clin Epidemiol. 1999; 52:1143-1156
12. Goldman DP, Berry SH, McCabe MS, et al. Incremental treatment costs in National Cancer Institute-sponsored clinical trials. JAMA. 2003;289:2970-2977.
13. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004; 22:730-734.
14. Gross CP, Herrin J, Wong N, Krumholz HM. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol. 2005; 23:4755-4763.
15. Crosson, K, Eisner E, Brown C, Ter Maat J. Primary care physicians' attitudes, knowledge, and practices related to cancer clinical trials. J Cancer Educ. 2001;16:188-192.
16. Howerton MW, Gibbons MC, Baffi CR, et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer. 2007;109: 465-476.
17. Hudson SV, Momperousse D, Leventhal H. Physician perspectives on cancer clinical trials and barriers to minority recruitment. Cancer Control. 2005; 12:93-96
18. Getz KA. Racial disparities among clinical research investigators. Am J Ther. 2008;15: 319.
19. Ford JG, Howerton MW, Bolen S, et al. Knowledge and Access to Information on Recruitment of Underrepresented Populations to Cancer Clinical Trials. Evidence Report: Technology Assessment No.122, AHRQ Publication No. 05-E019-2. Rockville, MD. Agency for Healthcare Research and Quality. June 2005.
20. Geller EG, Goldstein M, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. Journal of Women's Health. 2006;15:1123-1131.
21. Fouad MN, Partridge E, Green BL, Wynn T, Nagy S, Churchill S. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol. 2000; 10: S35-40.
22. Increasing minority participation in clinical research: a white paper from the Endocrine Society. December 2007. Available from: http://www.endo- society.org/advocacy/health-disparities/index.cfm# Accessed November, 18, 2009.
23. Noah, BA. The participation of underrepresented populations in clinical research. J Law Med Med. 2003:29:221-224.
24. Rdesinski RE, Melnick AL, Creach ED, Cozzens J, Carney PA. The cost of recruitment and retention of women from community-based programs into a randomized controlled contraceptive study. J Health Care Poor Underserved. 2008;19:639-651